MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host a virtual investor conference focused on cardiology, cardiovascular, and neurovascular on Tuesday, December 8 through Friday, December 11. The conference will be titled the MedInvest Cardiovascular and Neurovascular Investor Conference. The event will be hosted virtually, given the continuing risks to participants at physical events resulting from COVID-19.
The conference is expected to attract 200+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The first two days will consist of half a dozen talks by KOLs and investor panels, headlined by the Founder of St. Jude Medical as the keynote. The final two days will focus on individual one-on-one meetings between conference participants, including, but not limited to, meetings between investors and presenting companies, facilitated by MedInvest's virtual partnering system.
Presenting companies, investors, and sponsors/service providers can register/apply for the event here.
Comments